164 related articles for article (PubMed ID: 33326821)
1. C6 peptide enzyme immunoassay in Lyme borreliosis serology.
Rouhiainen M; Pietikäinen A; Kortela E; Kanerva MJ; Oksi J; Hytönen J
J Microbiol Methods; 2021 Jan; 180():106122. PubMed ID: 33326821
[TBL] [Abstract][Full Text] [Related]
2. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
[TBL] [Abstract][Full Text] [Related]
4. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.
Lipsett SC; Branda JA; McAdam AJ; Vernacchio L; Gordon CD; Gordon CR; Nigrovic LE
Clin Infect Dis; 2016 Oct; 63(7):922-8. PubMed ID: 27358358
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
Lipsett SC; Branda JA; Nigrovic LE
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
[TBL] [Abstract][Full Text] [Related]
8. Two-Tier Lyme Disease Serology Test Results Can Vary According to the Specific First-Tier Test Used.
Maulden AB; Garro AC; Balamuth F; Levas MN; Bennett JE; Neville DN; Branda JA; Nigrovic LE
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):128-133. PubMed ID: 30793167
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
10. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests.
Goossens HA; Maes JH; van den Bogaard AE
Tijdschr Diergeneeskd; 2003 Nov; 128(21):650-7. PubMed ID: 14650723
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of Lyme borreliosis in Scottish patients: a novel approach.
Mavin S; Watson EJ; Evans R
Br J Biomed Sci; 2014; 71(2):51-4. PubMed ID: 24974678
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of C6 Enzyme Immunoassay for Lyme Arthritis.
Nigrovic LE; Bennett JE; Balamuth F; Levas MN; Neville D; Lyons TW; Branda JA; Maulden AB; Lewander D; Garro A;
Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31836615
[TBL] [Abstract][Full Text] [Related]
15. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
[TBL] [Abstract][Full Text] [Related]
16. Higher C6 enzyme immunoassay index values correlate with a diagnosis of noncutaneous Lyme disease.
Nigrovic LE; Lipsett SC; Molins CR; Wormser GP; Bennett JE; Garro AC; Levas MN; Balamuth F; Neville D; Lingampalli N; Robinson WH; Branda JA
Diagn Microbiol Infect Dis; 2019 Jun; 94(2):160-164. PubMed ID: 30642722
[TBL] [Abstract][Full Text] [Related]
17. Improved serodiagnosis of early Lyme borreliosis: immunoblot with local Borrelia afzelii strain.
Jovicić VLj; Grego EM; Lako BL; Ristović BM; Lepsanović ZA; Stajković NT
APMIS; 2003 Nov; 111(11):1053-9. PubMed ID: 14629271
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies against Borrelia afzelii, Borrelia burgdorferi sensu stricto and the 41-kiloDalton flagellin in patients from a Lyme borreliosis endemic area: analysis by EIA and immunoblot.
Nilsson I; von Rosen IA
APMIS; 1996 Dec; 104(12):907-14. PubMed ID: 9048870
[TBL] [Abstract][Full Text] [Related]
19. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
[TBL] [Abstract][Full Text] [Related]
20. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
